A Double-blind, Randomized, Crossover Clinical Trial comparing VIM vs. PSA Deep Brain Stimulation for Disabling Essential Tremor
Objective: To compare the efficacy, safety, energy efficiency and quality of life (QoL) of bilateral PSA-DBS versus bilateral VIM-DBS in the treatment of essential tremor…REM sleep behavior disorder and Prodromal Parkinson’s Disease in patients with Essential Tremor
Objective: To assess the prevalence of REM sleep behaviour disorder (RBD) and Prodromal Parkinson's Disease (PPD) in Essential Tremor (ET) and to characterize these sub-groups…Comparative assessment of cognitive functions of patients with ET and ET plus.
Objective: to conduct a comparative analysis of changes in neurological status and cognitive decline of various types of essential tremor (ET). Background: in the new…SAGE-324/BIIB124, an investigational GABAA receptor PAM, for treatment of essential tremor
Objective: KINETIC2 is a multicenter, randomized, placebo-controlled, dose-response Ph2b study evaluating SAGE-324/BIIB124 for treatment of essential tremor (ET). Background: ET is a common movement disorder1,2…Vim DBS for Post-Stroke Tremor: A Case Report
Objective: We report a unique case of post-stroke tremor (PST) with a robust response to deep brain stimulation (DBS) of the ventral intermediate nucleus of…Tractography-guided versus Clinical Determination of the Most Effective Contact for Tremor Control in Patients with Deep Brain Stimulation – A Clinical Trial
Objective: To prospectively test the hypothesis whether imaging-guided contact selection based on standardized individual tractography of the dentato-rubro-thalamic tract (DRTT) is non-inferior to clinical contact…Clinical Assessment Of Dysautonomia And REM Sleep Behavior Disorders in Essential Tremor
Objective: To assess the frequency of Rapid Eye Movement (REM) Sleep Behavior Disorder (RBD) and dysautonomic symptoms in Essential Tremor (ET) patients and to identify…Once-Daily Suvecaltamide Pharmacokinetics, Safety, & Tolerability–Phase 1, Randomized, Double-Blind, Multiple Ascending Dose Study
Objective: Evaluate the pharmacokinetics (PK), safety, and tolerability of a once-daily (QD) suvecaltamide (JZP385) formulation and its major active metabolites (JZZ05000034=M01, JZZ05000035=M02) in a Phase…Deep brain stimulation of bilateral ventral intermediate nucleus in patients with neuronal intranuclear inclusion disease
Objective: To evaluate the effect and the side effects of deep brain stimulation on the tremor of a patient with neuronal intranuclear inclusion disease (NIID).…Dentato-Rubro-Thalamic Tract Deep Brain Stimualtion for Essential Tremor: Stimulation Parameters and Clinical Outcomes
Objective: To assess the stimulation parameters and 2-year clinical outcomes of deep brain stimulation (DBS) of the dentato-rubro-thalamic tract (DRTt) for the treatment of essential…
- « Previous Page
- 1
- …
- 13
- 14
- 15
- 16
- 17
- …
- 56
- Next Page »